MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems

Go back to MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems
Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.94 +0.02 (0.51%)
Previous Close $3.92    52 Week High $2.51 
Open $4.00    52 Week Low $0.41 
Day High $4.02    P/E N/A 
Day Low $3.83    EPS $-0.64 
Volume 16,622,955       

Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.94 +0.02 (0.51%)
Previous Close $3.92    52 Week High $2.51 
Open $4.00    52 Week Low $0.41 
Day High $4.02    P/E N/A 
Day Low $3.83    EPS $-0.64 
Volume 16,622,955